Cargando…

Lv4, an activity that restricts nuclear entry of SIV(MAC)/SIV(SM) in human blood cells

Detalles Bibliográficos
Autores principales:	Pizzato, Massimo, Neagu, Martha, Pertel, Thomas, Firrito, Claudia, Ziglio, Serena, Zufferey, Madeleine, Berthoux, Lionel, Luban, Jeremy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848170/ http://dx.doi.org/10.1186/1742-4690-10-S1-O28

Ejemplares similares

Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIV(MAC)/SIV(SM)/HIV-2 Lineage Prior to Integration
por: Pizzato, Massimo, et al.
Publicado: (2015)

TRIM5alpha contributes to the anti-viral state
por: Pertel, Thomas, et al.
Publicado: (2009)

A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
por: Jensen, K, et al.
Publicado: (2012)

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV(mac)239
por: Jia, Bin, et al.
Publicado: (2009)

The HIV-2/SIV(SM )Vpx protein and an antiviral restriction in primary myeloid cells
por: Berger, Gregory, et al.
Publicado: (2009)

Acute infection by SIV: massive immunological damage
por: Roederer, Mario
Publicado: (2006)

Tetherin antagonism by HIV-1 and its SIV precursors
por: Kirchhoff, Frank
Publicado: (2011)

OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge
por: Kannanganat, S, et al.
Publicado: (2009)

Identifying features of the lentiviral genome crucial for the establishment of latency
por: Ziglio, Serena, et al.
Publicado: (2013)

Potent restriction of HIV-1 and SIV(mac239) Replication by African Green Monkey TRIM5α
por: Coren, Lori V, et al.
Publicado: (2015)

ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIV(mac)251 Challenge
por: Alpert, Michael D., et al.
Publicado: (2012)

Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIV(mac251) Rectal Challenge
por: Tuero, Iskra, et al.
Publicado: (2015)

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIV(mac251) acquisition in macaques
por: Rahman, Mohammad Arif, et al.
Publicado: (2023)

Understanding the benign nature of natural SIV infection: Implications for AIDS pathogenesis
por: Silvestri, Guido
Publicado: (2006)

GCM-SIV1.5: Optimal Tradeoff between GCM-SIV1 and GCM-SIV2
por: Zhang, Ping
Publicado: (2023)

TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner
por: Ohainle, Molly, et al.
Publicado: (2020)

Why are pathogenic SIV and HIV infections characterized by high level immune activation when other chronic virus infection are not? Lessons from nonpathogenic SIV infection in natural host species
por: Staprans, Silvija, et al.
Publicado: (2006)

Evidence for Env-V2 sieve effect in breakthrough SIV (MAC251) infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs
por: Sina, S, et al.
Publicado: (2012)

The Fourth Major Restriction Factor Against HIV/SIV
por: Nomaguchi, Masako, et al.
Publicado: (2011)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang, X, et al.
Publicado: (2012)

Rapid Dissemination of SIV Follows Multisite Entry after Rectal Inoculation
por: Ribeiro dos Santos, Patricia, et al.
Publicado: (2011)

Impaired RNA incorporation and dimerization in live attenuated leader-variants of SIV(mac239)
por: Whitney, James B, et al.
Publicado: (2006)

Virus-specific cellular immune correlates of survival in vaccinated monkeys after SIV challenge
por: Letvin, Norman
Publicado: (2006)

Early pro-inflammatory host response to recombinant HSV-SIV vaccination in sooty mangabeys
por: Rout, N, et al.
Publicado: (2012)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

Engagement of monocytes, NK cells, and CD4(+) Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIV(mac251) vaginal acquisition
por: Gorini, Giacomo, et al.
Publicado: (2020)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
por: Liu, J, et al.
Publicado: (2012)

Immune complexes can dampen inflammatory signaling at the mucosal surface during protective SIV vaccination
por: Smith, AJ, et al.
Publicado: (2012)

Intra-dermal immunisation with SIV gag-based vaccines alone inhibits acquisition of SIVmac251
por: Almond, N, et al.
Publicado: (2012)

Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
por: Sun, C, et al.
Publicado: (2012)

SIV Evolutionary Dynamics in Cynomolgus Macaques during SIV-Mycobacterium tuberculosis Co-Infection
por: Tisthammer, Kaho H., et al.
Publicado: (2021)

Perturbations in the CD4(+)CD25(+ )regulatory T cell population of the GALT during acute SIV infection
por: Chase, Amanda J, et al.
Publicado: (2006)

Occult replication of a conditionally-live attenuated SIV profoundly upregulates T effector memory cell frequency
por: Manoussaka, Maria, et al.
Publicado: (2011)

SIV replication in human cells
por: Sakuma, Ryuta, et al.
Publicado: (2012)

SIV Infection of Lung Macrophages
por: Li, Yue, et al.
Publicado: (2015)

Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection
por: Hao, Xing Pei, et al.
Publicado: (2015)

Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIV(mac239) in rhesus macaques
por: Laliberté, Alexandre, et al.
Publicado: (2023)

Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
por: Hamimi, C, et al.
Publicado: (2012)

Anti-retroviral innate immune responses in multiple lymphoid tissues elicited by protective live attenuated SIV vaccination
por: Mattiuzzo, Giada, et al.
Publicado: (2011)

SIVΔnef vaccination mobilizes systemic and mucosal natural killer cells in Mamu A*01+ macaques
por: Reeves, R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ie5hk3s9dbrd6smmmuk7dtpvbt